Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
Submitted by
admin
on February 12, 2016 - 4:19pm
Source:
Fortune
News Tags:
GSK
UK
generics
competition
Seroxat
antidepressants
Headline:
GlaxoSmithKline Fined $54.3 Million for Preventing Generic Competition
Do Not Allow Advertisers to Use My Personal information
